Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Marek Cierny MD

Marek Cierny MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Neurology
Division: General

Member of the Center for Advancing Population Science (CAPS)


I am willing to mentor a junior faculty member.
I am willing to collaborate on research projects.


Publications (8)

  • Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome. (Čierny M, Hooshmand SI, Fee D, Tripathi S, Dsouza NR, La Pean Kirschner A, Zimmermann MT, Brennan R) Parkinsonism Relat Disord 2020 08;77:110-113 PMID: 32712562 SCOPUS ID: 2-s2.0-85088215494 07/28/2020       3 Citations
  • Consistent improvement with eculizumab across muscle groups in myasthenia gravis. (Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr, REGAIN study group) Ann Clin Transl Neurol 2020 08;7(8):1327-1339 PMID: 32700461 PMCID: PMC7448154 SCOPUS ID: 2-s2.0-85088297453 07/24/2020       3 Citations
  • 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. (Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF, REGAIN study group) J Neurol 2020 Jul;267(7):1991-2001 PMID: 32189108 PMCID: PMC7320935 SCOPUS ID: 2-s2.0-85085089028 03/20/2020       6 Citations
  • Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis. (Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr, REGAIN Study Group) Qual Life Res 2019 Aug;28(8):2255 PMID: 31115842 PMCID: PMC6620249 SCOPUS ID: 2-s2.0-85066885728 05/23/2019    
  • Eculizumab improves fatigue in refractory generalized myasthenia gravis. (Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr, REGAIN Study Group) Qual Life Res 2019 Aug;28(8):2247-2254 PMID: 30905021 PMCID: PMC6620379 SCOPUS ID: 2-s2.0-85065135150 03/25/2019       18 Citations
  • Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. (Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr, Regain Study Group) Muscle Nerve 2019 07;60(1):14-24 PMID: 30767274 PMCID: PMC6619057 SCOPUS ID: 2-s2.0-85062729927 02/16/2019       67 Citations
  • Tick-borne meningitis complicated by a cardioembolic intraluminal carotid artery thrombus and stroke (Čierny M, Škorňa M, Peška S, Polák P, Voháňka S) Ceska a Slovenska Neurologie a Neurochirurgie 2019;82(2):227-228 SCOPUS ID: 2-s2.0-85068980383 01/01/2019    
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. (Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R, REGAIN Study Group) Lancet Neurol 2017 12;16(12):976-986 PMID: 29066163 SCOPUS ID: 2-s2.0-85035019720 10/27/2017       205 Citations
  • Last update: 10/11/2021